Avviso n. 19/2026: contratto di lavoro autonomo (professionale/occasionale) per lo svolgimento delle attività di supporto alla ricerca e elaborazione dati al fine del completamento dei progetti dal titolo: “A Phase 1, open label study of intravenous GSK3745417 to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and determine RP2D and schedule in participants with relapsed or refractory myeloid malignancies including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS)”; “A randomized, open-label, controlled, Phase 2 study of Pevonedistat, Venetoclax, and Azacitidine versus Venetoclax plus Azacitidine in adults with newly diagnosed acute myeloid leukemia who are unfit for intensive chemotherapy” e “A phase 3, randomized open-label study evaluating the safety and efficacy of Magrolimab in combination with Azacitidine versus physician's choice of Venetoclax in combination with Azacitidine or intensive chemotherapy in previously untreated patients with TP53 mutant Acute Myeloid Leukemia” <br /> <br />